Skip to main content

Advertisement

SpringerLink
Log in

Serum galectin-3 levels were associated with proteinuria in patients with Familial Mediterranean Fever

  • Original Article
  • Published:
Clinical and Experimental Nephrology Aims and scope Submit manuscript

Abstract

Background

The most common and pernicious complication of Familial Mediterranean fever (FMF) is renal amyloidosis, usually affecting the kidneys, leading to end-stage renal failure. FMF-related renal amyloidosis needed to be diagnosed early. Optimal colchicine dose is effective in preventing and reversing renal amyloidosis. Galectin-3, profibrotic mediator, has regulatory functions in inflammation, fibrosis and tumorigenesis. Galectin-3 is a strong prognostic marker for heart failure. Galectin-3 plays role in diabetic nephropathy and chronic kidney disease. The aim of the study is to investigate whether galectin-3 is related to proteinuria and amyloidosis in FMF.

Methods

Seventy-five FMF patients who have no exclusion criteria and healthy controls (n = 36) were included. Serum galectin-3 was measured and morning spot urine was collected for determination of the protein/creatinine ratio (PCR).

Results

Serum Galectin-3 levels were significantly higher in FMF patients than the control group [969.66 (3825) pg/mL vs. 238 (921) pg/mL, respectively; P<0.001]. We classified into two groups: Group1 (n = 48) had FMF patients with proteniuria, Group2 (n = 27) had FMF patients without proteinuria. Group1 had higher levels of galectin-3 than Group2 [1106(3812) pg/mL vs. 867.3(1433) pg/mL, P < 0.001]. Galectin-3 levels were correlated with PCR in whole group and FMF group (r = 0.785, P < 0.001 and r = 0.803, P < 0.001). In ROC curve, best cutoff value = 581.50 pg/mL was used to detect proteinuria (sensitivity = 91.7 %, specificity = 71.4 %, AUC = 0.879) and optimal cutoff value = 1458.00 pg/mL was an indicator of nephrotic-range proteinuric (sensitivity = 100 %, specificity = 92.1 %, AUC = 0.983).

Conclusion

Galectin-3 is associated with proteinuria and renal amyloidosis in FMF. Galectin-3 may play role in pathogenesis of amyloidosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Soriano A, Manna R. Familial Mediterranean fever: new phenotypes. Autoimmun Rev. 2012;12:31–7.

    Article  PubMed  Google Scholar 

  2. Portincasa P, Scaccianoce G, Palasciano G. Familial Mediterranean fever: a fascinating model of inherited autoinflammatory disorder. Eur J Clin Invest. 2013;43(12):1314–27.

    Article  CAS  PubMed  Google Scholar 

  3. Onen F. Familial Mediterranean fever. Rheumatol Int. 2006;26:489–96.

    Article  PubMed  Google Scholar 

  4. Lidar M, Livneh A. Familial Mediterranean fever: clinical, molecular and management advancements. Neth J Med. 2007;65(9):318–24.

    CAS  PubMed  Google Scholar 

  5. Pinney JH, Lachmann HJ. Systemic AA amyloidosis. Subcell Biochem. 2012;65:541–64.

    CAS  PubMed  Google Scholar 

  6. Sohar E, Gafni J, Pras M, Heller H. Familial Mediterranean fever. A survey of 470 cases and review of the literature. Am J Med. 1967;43(2):227–53.

    Article  CAS  PubMed  Google Scholar 

  7. Pras M, Bronshpigel N, Zemer D, Gafni J. Variable incidence of amyloidosis in familial Mediterranean fever among different ethnic groups. Johns Hopkins Med J. 1982;150:22–6.

    CAS  PubMed  Google Scholar 

  8. Tunca M, Akar S, Onen F, Ozdogan H, Kasapcopur O, Yalcinkaya F, Tutar E, Ozen S, Topaloglu R, Yilmaz E, Arici N, Bakkaloglu A, Besbas N, Akpolat T, Dinc A, Erken E, Turkish FMF study group. Familial Mediterranean fever in Turkey. Results of a nationwide multicenter study. Medicine. 2005;84:1–11.

    Article  PubMed  Google Scholar 

  9. Ben-Chetrit E, Levy M. Familial Mediterranean fever. Lancet. 1998;351:659–64.

    Article  CAS  PubMed  Google Scholar 

  10. Drenth JP, van der Meer JW. Hereditary periodic fever. N Engl J Med. 2001;345(24):1748–57.

    Article  CAS  PubMed  Google Scholar 

  11. de Boer RA, Voors AA, MuntendamP, vanGilstWH, van Veldhuisen DJ. Galectin-3: a novel mediator of heart failure development and progression. Eur J Heart Fail. 2009;11:811–7.

    Article  PubMed  Google Scholar 

  12. Henderson NC, Sethi T. The regulation of inflammation by galectin-3. Immunol Rev. 2009;230(1):160–71.

    Article  CAS  PubMed  Google Scholar 

  13. Pugliese G, Pricci F, Iacobini C, Leto G, Amadio L, Barsotti P, Frigeri L, Hsu DK, Vlassara H, Liu F-T, Di Mario U. Accelerated diabetic glomerulopathy in galectin-3/AGE receptor 3 knockout mice. FASEB J. 2001;15(13):2471–9.

    Article  CAS  PubMed  Google Scholar 

  14. Iacobini C, Amadio L, Oddi G, Ricci C, Barsotti P, Missori S, Sorcini M, Di Mario U, Pricci F, Pugliese G. Role of galectin-3 in diabetic nephropathy. J Am Soc Nephrol. 2003;14:S264–70.

    Article  CAS  PubMed  Google Scholar 

  15. Henderson NC, Mackinnon AC, Farnworth SL, Kipari T, Haslett C, Iredale JP, Liu FT, Hughes J, Sethi T. Galectin-3 expression and secretion links macrophages to the promotion of renal fibrosis. Am J Pathol. 2008;172:288–98.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  16. Dang Z, MacKinnon A, Marson LP, Sethi T. Tubular atrophy and interstitial fibrosis after renal transplantation is dependent on galectin-3. Transplantation. 2012;93:477–84.

    Article  CAS  PubMed  Google Scholar 

  17. O’Seaghdha CM, Hwang SJ, Ho JE, Vasan RS, Levy D, Fox CS. Elevated galectin-3 precedes the development of CKD. J Am Soc Nephrol. 2013;24:1470–7.

    Article  PubMed Central  PubMed  Google Scholar 

  18. Friedman EA, Brittain E, Su YR, LeBoeuf J, Sawyer D, Lenihan D. Markedly elevated galectin-3 levels in cardiac amyloidosis may indicate significant fibrosis. J Cardiac Fail. 2013;19(8):S63.

    Article  Google Scholar 

  19. Livneh A, Langevitz P, Zemer D, Zaks N, Kees S, Lidar T, et al. Criteria for the diagnosis of familial Mediterranean fever. Arthr Rheum. 1997;40:1879–85.

    Article  CAS  Google Scholar 

  20. Pras E, Livneh A, Balow JE, Kastner DL, Pras M, Langevitz P. Clinical differences between North African and Iraqi Jews with familial Mediterranean fever. Am J Med Genet. 1998;75:216–9.

    Article  CAS  PubMed  Google Scholar 

  21. Schwab SJ, Christensen RL, Dougherty K, Klahr S. Quantitation of proteinuria by the use of protein-to-creatinine ratios in single urine samples. Arch Intern Med. 1987;147(5):943–4.

    Article  CAS  PubMed  Google Scholar 

  22. Ginsberg JM, Chang BS, Matarese RA, Garella S. Use of single voided urine samples to estimate quantitative proteinuria. N Engl J Med. 1983;309(25):1543–6.

    Article  CAS  PubMed  Google Scholar 

  23. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 1982;143:29–36.

    Article  CAS  PubMed  Google Scholar 

  24. Matsunaga N, Anan I, Rosenberg P, Nagai R, Lundström O, Horiuchi S, Ando Y, Suhr OB. Advanced glycation end product is implicated in amyloid-related kidney complications. Scand J Clin Lab Invest. 2005;65(4):263–72.

    Article  CAS  PubMed  Google Scholar 

  25. Bohle A, Wehrmann M, Eissele R, von Gise H, Mackensen-Haen S, Muller C. The long-term prognosis of AA and AL renal amyloidosis and the pathogenesis of chronic renal failure in renal amyloidosis. Pathol Res Pract. 1993;189:316–31.

    Article  CAS  PubMed  Google Scholar 

  26. Sen S, Sarsik B. A proposed histopathologic classification, scoring, and grading system for renal amyloidosis: standardization of renal amyloid biopsy report. Arch Pathol Lab Med. 2010;134(4):532–44.

    PubMed  Google Scholar 

  27. Ben-Zvi I, Livneh A. Chronic inflammation in FMF: markers, risk factors, outcomes and therapy. Nat Rev Rheumatol. 2011;7(2):105–12.

    Article  CAS  PubMed  Google Scholar 

  28. Yalçinkaya F, Cakar N, Acar B, Tutar E, Güriz H, Elhan AH, Oztürk S, Kansu A, Ince E, Atalay S, Girgin N, Doğru U, Aysev D, Ekim M. The value of the levels of acute phase reactants for the prediction of familial Mediterranean fever associated amyloidosis: a case control study. Rheumatol Int. 2007;27(6):517–22.

    Article  PubMed  Google Scholar 

  29. Düzova A, Bakkaloğlu A, Beşbaş N, Topaloğlu R, Özen S, Özaltin F, Başsoy Y, Yilmaz E. Role of A-SAA in monitoring subclinical inflammation and in colchicines dosage in familial Mediterranean fever. Clin Exp Rheum. 2003;21:509–14.

    Google Scholar 

  30. Gillmore JD, Lovat LB, Persey MR, Pepys MB, Hawkins PN. Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein. Lancet. 2001;358:24–9.

    Article  CAS  PubMed  Google Scholar 

  31. Yalcinkaya F, Turner N. Glomerular lesions other than amyloidosis in patients with FMF. Nephrol Dial Transplant. 1999;14:21–3.

    Article  CAS  PubMed  Google Scholar 

  32. Akpolat T, Akpolat I, Karagoz F, et al. Familial Mediterranean fever and glomerulonephritis and review of the literature. Rheumatol Int. 2004;24:43–5.

    Article  PubMed  Google Scholar 

  33. Said R, Hamzeh Y, Said S, et al. Spectrum of renal involvement in FMF. Kidney Int. 1992;41:414–9.

    Article  CAS  PubMed  Google Scholar 

Download references

Conflict of interest

All the authors have declared no competing interest.

Author information

Authors and Affiliations

  1. Department of Internal Medicine, Section of Nephrology, School of Medicine, Turgut Ozal University, Alparslan Türkes Cad. No: 57, Emek, 06510, Ankara, Turkey

    Hakki Yilmaz, Mukadder Ayse Bilgic & Ali Akcay

  2. Department of Internal Medicine, Yenimahalle State Hospital, Ankara, Turkey

    Osman Inan

  3. Department of Internal Medicine, Agri State Hospital, Agri, Turkey

    Tahir Darcin

Authors
  1. Hakki Yilmaz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Osman Inan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Tahir Darcin
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Mukadder Ayse Bilgic
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ali Akcay
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hakki Yilmaz.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yilmaz, H., Inan, O., Darcin, T. et al. Serum galectin-3 levels were associated with proteinuria in patients with Familial Mediterranean Fever. Clin Exp Nephrol 19, 436–442 (2015). https://doi.org/10.1007/s10157-014-1009-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10157-014-1009-7

Keywords

Search

Navigation